title: Characterizing the anti-tumor function of adoptively transferred NK cells in vivo.
abstract: Natural killer (NK) cells represent a promising cell type to utilize for effective adoptive immunotherapy. However, little is known about the important cytolytic molecules and signaling pathways used by NK cells in the adoptive transfer setting. To address this issue, we developed a novel mouse model to investigate the trafficking and mechanism of action of these cells. We demonstrate that methylcholanthrene-induced RKIK sarcoma cells were susceptible to NK cell-mediated lysis in vitro and in vivo following adoptive transfer of NK cells in C57BL/6 RAG-2(-/-)gammac(-/-) mice. Cytotoxic molecules perforin, granzymes B and M as well as the death ligand TRAIL and pro-inflammatory cytokine IFN-gamma were found to be important in the anti-tumor effect mediated by adoptively transferred NK cells. Importantly, we demonstrate that adoptively transferred NK cells could traffic to the tumor site and persisted in vivo which correlated with the anti-tumor effect observed. Overall, the results of this study have important implications for enhancing NK cell-based immunotherapies.
authors.affiliation: Cancer Immunology Program, Cancer Immunotherapy Research Laboratory, Peter MacCallum Cancer Centre, 14 St Andrews Place, East Melbourne, VIC, 3002, Australia.
authors.forename: Hollie J
authors.initials: HJ
authors.lastname: Pegram
authors.forename: Nicole M
authors.initials: NM
authors.lastname: Haynes
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Smyth
authors.forename: Michael H
authors.initials: MH
authors.lastname: Kershaw
authors.forename: Phillip K
authors.initials: PK
authors.lastname: Darcy
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D003602:Cytotoxicity, Immunologic; D004268:DNA-Binding Proteins / Q000235:genetics; D016219:Immunotherapy, Adoptive; D007376:Interleukin-2 / Q000276:immunology / Q000378:metabolism; D007694:Killer Cells, Natural / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D008213:Lymphocyte Activation; D008748:Methylcholanthrene; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008817:Mice, Mutant Strains; D012513:Sarcoma, Experimental / Q000276:immunology* / Q000473:pathology / Q000628:therapy*
chemical_list: D004268:DNA-Binding Proteins; D007376:Interleukin-2; C499308:Rag2 protein, mouse; D008748:Methylcholanthrene